登录方式
方式一:
PC端网页:www.rccrc.cn
输入账号密码登录,可将此网址收藏并保存密码方便下次登录
方式二:
手机端网页:www.rccrc.cn
输入账号密码登录,可将此网址添加至手机桌面并保存密码方便下次登录
方式三:
【重症肺言】微信公众号
输入账号密码登录
注:账号具有唯一性,即同一个账号不能在两个地方同时登录。
【摘要】闭塞性细支气管炎综合征(bronchiolitis obliterans syndrome,BOS) 是最常见的慢性肺移植物失功能的非感染形式。随着2019年国际心肺移植学会(International Society for Heart and Lung Transplantation,ISHLT)更新了BOS相关定义、诊断和治疗,目前对该类疾病有了新的认识。本文将对BOS的综合诊断方式和潜在治疗策略进行总结,为BOS的发生、发展的早期监测和管理提供理论参考。
[1] Levy L, Huszti E, Renaud-Picard B, et al. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system[J]. J Heart Lung Transplant, 2020, 39(8):761-770.
[2] Chambers D C, Perch M, Zuckermann A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics[J]. J Heart Lung Transplant, 2021, 40(10):1060-1072.
[3 ]Hakim A, Cooke K R, Pavletic S Z,. et al. Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally[J]. Bone Marrow Transplant, 2019, 54(3):383-392.
[4] Kulkarni H S, Cherikh W S, Chambers D C, et al. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis[J]. J Heart Lung Transplan, 2019, 38(1):5-16.
[5] Verleden G M, Glanville A R, Lease E D, et al. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT[J]. J Heart Lung Transplant, 2019, 38(5):493-503.
[6] Abedin S, Yanik G A, Braun T, et al. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung[J]. Biol Blood Marrow Transplant, 2015, 21(6):1127-1131.
[7] Nishimoto K, Karayama M, Inui N, et al. Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma[J]. Sci Rep, 2017, 7(1):10187.
[8] Leung A N, Fisher K, Valentine V, et al. Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT[J]. Chest, 1998, 113(2):365-370.
[9] Vogel M, Brodoefel H, Bethge W, et al. Spontaneous thoracic air-leakage syndrome in patients following allogeneic hematopoietic stem cell transplantation: causes, CT-follow up and patient outcome[J]. Eur J Radiol, 2006, 60(3):392-397.
[10] Driskel M, Horsley A, Fretwell L,et al. Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome[J]. ERJ Open Res, 2019, 5(4):00164-2019.
[11] Nakashima M, Shinya T, Oto T, et al. Diagnostic value of ventilation/perfusion single-photon emission computed tomography/computed tomography for bronchiolitis obliterans syndrome in patients after lung transplantation[J]. Nucl Med Commun, 2019, 40(7):703-710.
[12] Gast K K, Biedermann A, Herweling A, et al. Oxygen-sensitive 3He-MRI in bronchiolitis obliterans after lung transplantation[J]. Eur Radiol, 2008, 18(3):530-537.
[13] Walkup L L, Myers K, El-Bietar J, et al. Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry[J]. Eur Respir J, 2019, 53(5):1801779.
[14] Verleden S E, Gheysens O, Goffin K E, et al. Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation[J]. Transplantation, 2019, 103(4):823-831.
[15] Davidsen J R, Laursen C B, Højlund M, et al. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study[J]. J Clin Med, 2021, 10(5):1078.
[16] Vos R, Vanaudenaerde B M, Verleden S E, et al. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis[J]. J Heart Lung Transplant, 2010, ;29(11):1259-1269.
[17] Berastegui C, Gómez-Ollés S, Sánchez-Vidaurre S, et al. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients[J]. Clin Transplant, 201, 31(3). Epub 2017 Jan 27.
[18] Belperio J A, Keane M P, Burdick M D, et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome[J]. J Immunol, 2002, 169(2):1037-1049.
[19] DerHovanessian A, Weigt S S, Palchevskiy V, et al. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome[J]. Am J Transplant, 2016, 16(2):640-649.
[20] Lobo L J, Aris R M, Schmitz J, et al. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation[J]. J Heart Lung Transplant, 2013, 32(1):70-77.
[21] Haberman B, Doan M L, Smith EO, et al. Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients[J]. Pediatr Transplant, 2010, 14(7):903-908.
[22] Ohshimo S, Bonella F, Sommerwerck U,et al. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation[J]. J Heart Lung Transplant, 2011, 30(12):1374-1380.
[23] Cameli P, Bargagli E, Fossi A, et al. Exhaled nitric oxide and carbon monoxide in lung transplanted patients[J]. Respir Med, 2015, 109(9):1224-1229.
[24] Siddiqui A S, Kumar G, Majumdar T, et al. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients[J]. Clin Transplant, 2018, 32(10):e13397.
[25] Benden C, Haughton M, Leonard S, et al. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review[J]. J Heart Lung Transplant, 2017, 36(9):921-933.
[26] Gottlieb J, Szangolies J, Koehnlein T, et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation[J]. Transplantation, 2008, 85(1):36-41.
[27] Federica M, Nadia S, Monica M, et al. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection[J]. Clin Transplant, 2011, 25(4):E381-E389.
[28] Cao X P, Han D M, Wang Z D,et al. [Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation][J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2016, 24(1):173-177.
[29] Keller C A, Gonwa T A, Hodge D O,et al. Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction[J]. Stem Cells Transl Med, 2018, 7(2):161-167.
[30] Date H, Lynch J P, Sundaresan S, et al. The impact of cytolytic therapy on bronchiolitis obliterans syndrome[J]. J Heart Lung Transplant, 1998, 17(9):869-875.
[31] Iacono A T, Corcoran T E, Griffith B P, et al. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans[J]. Eur Respir J, 2004, 23(3):384-390.
[32] Iacono A, Wijesinha M, Rajagopal K, et al. A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation[J]. ERJ Open Res, 2019, 5(4):00167-2019.
[33] Hayes D Jr, Zwischenberger J B, Mansour H M. Aerosolized tacrolimus: a case report in a lung transplant recipient[J]. Transplant Proc, 2010, 42(9):3876-3879.
[34] Lebeer M, Kaes J, Lambrech M, et al. Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature[J]. Transpl Int, 2020, 33(2):216-228.
[35] Fisher A J, Rutherford R M, Bozzino J,et al. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation[J]. Am J Transplant, 2005, 5(3):537-543.
[36] Jaksch P, Scheed A, Keplinger M, et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation[J]. J Heart Lung Transplant, 2012, 31(9):950-957.
[37] Varsch K E, Kang P, Huang J, et al. Lung Retransplantation for Chronic Rejection: A Single-Center Experience[J]. Ann Thorac Surg, 2018, 105(1):221-227.
友情链接
联系我们